| Term 
 
        | if LVEF is <40 what type of HF? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | which illict drug cna cause HF? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are causes of HF exacerbations-3 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AHA stages: high risk for HF but no strucutral problems or symtpoms
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AHA stages: strucutral heart disease but no symtpoms
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AHA stages: strucutral heart disease w/ prior or current symtpoms
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AHA stages: refractory HF neededing speical intervention
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NYHA stages: no limitaiton of activity
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NYHA stages: slight limitaiton, comfotable at rest
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NYHA stages: marked limitation, comfortable at rest
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NYHA stages: inabiltiy to carry on acitivty wihtout discomfort, not comfortable at rest
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what type of ADHF: PCWP>15-18 and
 CI >1.8-2
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what type of ADHF: PCWP>15-18 and
 CI <1.8-2
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what type of ADHF: PCWP<15-18 and
 CI <1.8-2
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | symtpoms fo volume overload-2 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | look at slide 43 for quck reveiw of diuretics |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Go to diuretic is- whats another?
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | dosing for furosemide PO IV?
 for torsemide?
 |  | Definition 
 
        | 20 mg BID 20 mg BID
 20 mg PO daily
 |  | 
        |  | 
        
        | Term 
 
        | look at sldie 44 right beofre assessment for diuretic dosing |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | electrolytes hypotension
 renal
 |  | 
        |  | 
        
        | Term 
 
        | monitoring for diuretics-3 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | if diuretics arent successful use-3 |  | Definition 
 
        | dopaamine low dose vasodilators
 inotrope
 |  | 
        |  | 
        
        | Term 
 
        | indicaitons for monitoring of hemodynamics-3 |  | Definition 
 
        | systilic pressure low w/ therapy worsening renal funct
 require vasoactive agents
 |  | 
        |  | 
        
        | Term 
 
        | what is the vasodilator with least affect on decreasing SVR? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what do nitroprusside and nesiritide increase?-1 decrease-3
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the vasodilators? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | how does nitroprusside work? |  | Definition 
 
        | reduce afterload to icnrease CO with vasodilating |  | 
        |  | 
        
        | Term 
 
        | what is nitroprusside a combo with mostly |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | renal dys/ cyanide toxicity |  | 
        |  | 
        
        | Term 
 
        | symtpoms fo cyanide toxicity-2 |  | Definition 
 
        | increase lactate altered metnal status
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | for the nitrates, do you want to use agressive or non aggressive dosing? |  | Definition 
 
        | aggresive- shown to be better in trials |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | which drug is recombant of human BNP? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | cost no head-head trials
 mo mortality beenfit
 |  | 
        |  | 
        
        | Term 
 
        | what is the bridge therapy to transplant? |  | Definition 
 
        | left ventricular assist device |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopamaine dobutamine
 milirone
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | look at slide 53 for effects of the inotrops right before assessment |  | Definition 
 | 
        |  |